FDA Drug Application (021366) for CRESTOR by IPR

Back to FDA Applications sponsored by IPR

Application Number021366
Product Number002
FormTABLET;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCRESTOR
Active IngredientROSUVASTATIN CALCIUM

Active IngredientCount
List of drugs with Active Ingredient ROSUVASTATIN CALCIUM2


Back to FDA Applications sponsored by IPR